Latest News and Press Releases

WILMINGTON, N.C., July 3, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a pioneer in minimally invasive approaches to lumbar spine surgery, today announced it has received CE (Conformité...

WILMINGTON, N.C., May 30, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today it will participate in two investor conferences in June. Ken Reali, President and Chief Executive...

First quarter revenues were $3.8 million Net loss per share was $0.21 for the quarter WILMINGTON, N.C., May 8, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company...

WILMINGTON, N.C., May 2, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief...

WILMINGTON, N.C., April 25, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release first quarter 2012 financial and operating results after market close on...

WILMINGTON, N.C., April 5, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing spine products to treat degenerative conditions...

- Fourth quarter revenues were $4.0 million - - 310 TranS1 procedures performed globally in the quarter - - Launch of VEOTM Lateral Access and Interbody Fusion System - - Net loss per share...

WILMINGTON, N.C., March 5, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing minimally invasive spine products to treat...

WILMINGTON, N.C., Feb. 24, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing minimally invasive spine products to treat...

WILMINGTON, N.C., Feb. 23, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release fourth quarter 2011 financial and operating results after market close on...